China Pharma (NYSE:CPHI) Coverage Initiated by Analysts at StockNews.com

Research analysts at StockNews.com started coverage on shares of China Pharma (NYSE:CPHI) in a report issued on Sunday. The firm set a “hold” rating on the stock.

China Pharma Stock Performance

Shares of CPHI opened at $0.20 on Friday. The company has a 50 day moving average price of $0.22 and a 200-day moving average price of $0.23. China Pharma has a fifty-two week low of $0.17 and a fifty-two week high of $0.69. The company has a quick ratio of 0.26, a current ratio of 0.79 and a debt-to-equity ratio of 0.22.

China Pharma Company Profile

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.